Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Greinacher

Showing results (21-30 of 166) with videos related to

Pageof 17
Sort By:
Der Internist|October 14, 2010
[Differential diagnosis and treatment of thrombocytopenia]V Kiefel, A Greinacher
Journal of Thrombosis and Haemostasis : JTH|June 23, 2015
Another surprising finding in heparin-induced thrombocytopenia--eat bigA Greinacher, M Delcea
Klinische Padiatrie|July 17, 1999
[The feasibility of preoperative autologous blood donation in children]A Dada, A Greinacher
Hamostaseologie|September 7, 2002
[Hirudins in the treatment of heparin-induced thrombocytopenia and in thrombosis prophylaxis]N Lubenow, A Greinacher
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 24, 2007
Heparin-induced thrombocytopenia: recommendations for optimal use of recombinant hirudinN Lubenow, A Greinacher
Transfusion Medicine (Oxford, England)|October 21, 2014
Why has the demand for platelet components increased? A commentaryA Greinacher, W Hoffmann
Vox Sanguinis|February 19, 2016
Predonation finger lancet punctures: a potential risk factor for interdonor pathogen transmission in the blood donor clinicA Greinacher, N Lubenow
Deutsche Medizinische Wochenschrift (1946)|August 5, 1999
[Current treatment concepts in heparin-induced thrombocytopenia]O Ranze, A Greinacher
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|January 20, 2004
Drugs for the prevention and treatment of thrombosis in patients with heparin-induced thrombocytopeniaN Lubenow, A Greinacher
Vox Sanguinis|January 1, 1993
Heparin-associated thrombocytopenia: no association of immune response with HLAA Greinacher, G Mueller-Eckhardt
Pageof 17

Showing results (21-30 of 166) with videos related to

Sort By:
Pageof 17
Der Internist|October 14, 2010
[Differential diagnosis and treatment of thrombocytopenia]V Kiefel, A Greinacher
Journal of Thrombosis and Haemostasis : JTH|June 23, 2015
Another surprising finding in heparin-induced thrombocytopenia--eat bigA Greinacher, M Delcea
Klinische Padiatrie|July 17, 1999
[The feasibility of preoperative autologous blood donation in children]A Dada, A Greinacher
Hamostaseologie|September 7, 2002
[Hirudins in the treatment of heparin-induced thrombocytopenia and in thrombosis prophylaxis]N Lubenow, A Greinacher
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 24, 2007
Heparin-induced thrombocytopenia: recommendations for optimal use of recombinant hirudinN Lubenow, A Greinacher
Transfusion Medicine (Oxford, England)|October 21, 2014
Why has the demand for platelet components increased? A commentaryA Greinacher, W Hoffmann
Vox Sanguinis|February 19, 2016
Predonation finger lancet punctures: a potential risk factor for interdonor pathogen transmission in the blood donor clinicA Greinacher, N Lubenow
Deutsche Medizinische Wochenschrift (1946)|August 5, 1999
[Current treatment concepts in heparin-induced thrombocytopenia]O Ranze, A Greinacher
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|January 20, 2004
Drugs for the prevention and treatment of thrombosis in patients with heparin-induced thrombocytopeniaN Lubenow, A Greinacher
Vox Sanguinis|January 1, 1993
Heparin-associated thrombocytopenia: no association of immune response with HLAA Greinacher, G Mueller-Eckhardt
Pageof 17